These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 19737552

  • 21. Cellular basis for improved left ventricular pump function after digoxin therapy in experimental left ventricular failure.
    McMahon WS, Holzgrefe HH, Walker JD, Mukherjee R, Arthur SR, Cavallo MJ, Child MJ, Spinale FG.
    J Am Coll Cardiol; 1996 Aug; 28(2):495-505. PubMed ID: 8800131
    [Abstract] [Full Text] [Related]

  • 22. S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction.
    Pleger ST, Remppis A, Heidt B, Völkers M, Chuprun JK, Kuhn M, Zhou RH, Gao E, Szabo G, Weichenhan D, Müller OJ, Eckhart AD, Katus HA, Koch WJ, Most P.
    Mol Ther; 2005 Dec; 12(6):1120-9. PubMed ID: 16168714
    [Abstract] [Full Text] [Related]

  • 23. Influence of ovariectomy in the right ventricular contractility in heart failure rats.
    Giuberti K, Pereira RB, Bianchi PR, Paigel AS, Vassallo DV, Stefanon I.
    Arch Med Res; 2007 Feb; 38(2):170-5. PubMed ID: 17227725
    [Abstract] [Full Text] [Related]

  • 24. The ongoing search for a stratified medicine approach in heart failure.
    Tang WH.
    J Am Coll Cardiol; 2008 Jun 17; 51(24):2310-2. PubMed ID: 18549914
    [No Abstract] [Full Text] [Related]

  • 25. Oxipurinol: alloxanthine, Oxyprim, oxypurinol.
    Drugs R D; 2004 Jun 17; 5(3):171-5. PubMed ID: 15139781
    [Abstract] [Full Text] [Related]

  • 26. Allopurinol or oxypurinol in heart failure therapy - a promising new development or end of story?
    Reyes AJ, Leary WP.
    Cardiovasc Drugs Ther; 2005 Oct 17; 19(5):311-3. PubMed ID: 16382292
    [Abstract] [Full Text] [Related]

  • 27. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study.
    Hare JM, Mangal B, Brown J, Fisher C, Freudenberger R, Colucci WS, Mann DL, Liu P, Givertz MM, Schwarz RP, OPT-CHF Investigators.
    J Am Coll Cardiol; 2008 Jun 17; 51(24):2301-9. PubMed ID: 18549913
    [Abstract] [Full Text] [Related]

  • 28. The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy.
    Springer J, Tschirner A, Hartman K, von Haehling S, Anker SD, Doehner W.
    Int J Cardiol; 2013 Oct 09; 168(4):3527-31. PubMed ID: 23751350
    [Abstract] [Full Text] [Related]

  • 29. Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy.
    Duncan JG, Ravi R, Stull LB, Murphy AM.
    Am J Physiol Heart Circ Physiol; 2005 Oct 09; 289(4):H1512-8. PubMed ID: 15863459
    [Abstract] [Full Text] [Related]

  • 30. Chromogranin B in heart failure: a putative cardiac biomarker expressed in the failing myocardium.
    Røsjø H, Husberg C, Dahl MB, Stridsberg M, Sjaastad I, Finsen AV, Carlson CR, Oie E, Omland T, Christensen G.
    Circ Heart Fail; 2010 Jul 09; 3(4):503-11. PubMed ID: 20519641
    [Abstract] [Full Text] [Related]

  • 31. Direct Evidence that Myocardial Insulin Resistance following Myocardial Ischemia Contributes to Post-Ischemic Heart Failure.
    Fu F, Zhao K, Li J, Xu J, Zhang Y, Liu C, Yang W, Gao C, Li J, Zhang H, Li Y, Cui Q, Wang H, Tao L, Wang J, Quon MJ, Gao F.
    Sci Rep; 2015 Dec 14; 5():17927. PubMed ID: 26659007
    [Abstract] [Full Text] [Related]

  • 32. Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts.
    Naumova AV, Chacko VP, Ouwerkerk R, Stull L, Marbán E, Weiss RG.
    Am J Physiol Heart Circ Physiol; 2006 Feb 14; 290(2):H837-43. PubMed ID: 16183726
    [Abstract] [Full Text] [Related]

  • 33. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure.
    Ekelund UE, Harrison RW, Shokek O, Thakkar RN, Tunin RS, Senzaki H, Kass DA, Marbán E, Hare JM.
    Circ Res; 1999 Sep 03; 85(5):437-45. PubMed ID: 10473673
    [Abstract] [Full Text] [Related]

  • 34. Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III - IV congestive heart failure.
    Freudenberger RS, Schwarz RP, Brown J, Moore A, Mann D, Givertz MM, Colucci WS, Hare JM.
    Expert Opin Investig Drugs; 2004 Nov 03; 13(11):1509-16. PubMed ID: 15500398
    [Abstract] [Full Text] [Related]

  • 35. Late exercise training improves non-uniformity of transmural myocardial function in rats with ischaemic heart failure.
    Aït Mou Y, Reboul C, Andre L, Lacampagne A, Cazorla O.
    Cardiovasc Res; 2009 Feb 15; 81(3):555-64. PubMed ID: 18703535
    [Abstract] [Full Text] [Related]

  • 36. Empagliflozin directly improves diastolic function in human heart failure.
    Pabel S, Wagner S, Bollenberg H, Bengel P, Kovács Á, Schach C, Tirilomis P, Mustroph J, Renner A, Gummert J, Fischer T, Van Linthout S, Tschöpe C, Streckfuss-Bömeke K, Hasenfuss G, Maier LS, Hamdani N, Sossalla S.
    Eur J Heart Fail; 2018 Dec 15; 20(12):1690-1700. PubMed ID: 30328645
    [Abstract] [Full Text] [Related]

  • 37. SERCA-2a is involved in the right ventricular function following myocardial infarction in rats.
    Fernandes AA, Ribeiro RF, de Moura VG, Siman FD, Dias FM, Zoghaib J, Vassallo PF, Vassallo DV, Stefanon I.
    Life Sci; 2015 Mar 01; 124():24-30. PubMed ID: 25625241
    [Abstract] [Full Text] [Related]

  • 38. Biochemical and mechanical dysfunction in a mouse model of desmin-related myopathy.
    Maloyan A, Osinska H, Lammerding J, Lee RT, Cingolani OH, Kass DA, Lorenz JN, Robbins J.
    Circ Res; 2009 Apr 24; 104(8):1021-8. PubMed ID: 19299643
    [Abstract] [Full Text] [Related]

  • 39. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion.
    Puett DW, Forman MB, Cates CU, Wilson BH, Hande KR, Friesinger GC, Virmani R.
    Circulation; 1987 Sep 24; 76(3):678-86. PubMed ID: 3621527
    [Abstract] [Full Text] [Related]

  • 40. Novel myofilament Ca2+-sensitizing property of xanthine oxidase inhibitors.
    Pérez NG, Gao WD, Marbán E.
    Circ Res; 1998 Aug 24; 83(4):423-30. PubMed ID: 9721699
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.